Mediterranean Journal of Hematology and Infectious Diseases

Guest Editor: Pellegrino Musto BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA: APPROPRIATE SELECTION OF PATIENTS AND SEQUENCING

Michele Puppi, Ilaria Sacchetti, Katia Mancuso, Paola Tacchetti, Lucia Pantani, ilaria Rizzello, Miriam Iezza, Marco Talarico, Enrica Manzato, Simone Masci, Roberta Restuccia, Simona Barbato, Silvia Armuzzi, Barbara Taurisano, Ilaria Vigliotta, Elena Zamagni

Abstract 1108 | PDF Downloads 911 HTML Downloads 105

Page e2025045

PDF HTML

DOI: https://doi.org/10.4084/MJHID.2025.045

LENALIDOMIDE IN COMBINATION WITH DEXAMETHASONE IN ELDERLY PATIENTS WITH ADVANCED, RELAPSED OR REFRACTORY MULTIPLE MYELOMA AND RENAL FAILURE

Patrizia Tosi

Abstract 1099 | PDF Downloads 803 HTML Downloads 1171 fig 1A Downloads 0 figure1B Downloads 0

Page e2013037

PDF HTML fig 1A figure1B

DOI: https://doi.org/10.4084/mjhid.2013.037

SOCIOECONOMIC STATUS IS GLOBALLY A PROGNOSTIC FACTOR FOR OVERALL SURVIVAL OF MULTIPLE MYELOMA PATIENTS; SYNTHESIS OF STUDIES AND REVIEW OF THE LITERATURE

Stergios Intzes, Marianthi Symeonidou, Konstantinos Zagoridis, Aikaterini Pentidou, Spanoudakis Emmanouil

Abstract 1702 | PDF Downloads 668 HTML Downloads 173

Page e2021006

PDF HTML

DOI: https://doi.org/10.4084/mjhid.2021.006

EARLY APPLICATION OF HIGH CUT-OFF HAEMODYALISIS FOR DE-NOVO MYELOMA NEPHROPATHY IS ASSOCIATED WITH LONG-TERM DIALYSIS-INDEPENDENCY AND RENAL RECOVERY

Alhossain A. Khalafallah, Sie Wuong Loi, Sarah Love, Muhajir B. Mohamed, Rose Mace, Ramy Khalil, Miriam Girgs, Rajesh Raj, Mathew Mathew

Abstract 1173 | PDF Downloads 547 HTML Downloads 2426 cover letter Downloads 0

Page e2013007

PDF HTML cover letter

DOI: https://doi.org/10.4084/mjhid.2013.007

Guest Editor: Pellegrino Musto HOW FIRST-LINE THERAPY IS CHANGING IN NON-TRANSPLANT ELIGIBLE MULTIPLE MYELOMA PATIENTS.

Daniele Derudas

Abstract 1107 | PDF Downloads 1048 HTML Downloads 77

Page e2025025

PDF HTML

DOI: https://doi.org/10.4084/MJHID.2025.025

Guest Editor: Pellegrino Musto HOW FIRST LINE THERAPY IS CHANGING IN TRANSPLANT-ELIGIBLE MULTIPLE MYELOMA PATIENTS

Yasmine Houbaida, Maria Livia Del Giudice, Sara Galimberti, Gabriele Buda

Abstract 1344 | PDF Downloads 1201 HTML Downloads 80

Page e2025026

PDF HTML

DOI: https://doi.org/10.4084/MJHID.2025.026

PLASMA CELL LEUKEMIA UPDATE ON IMMUNOPHENOTYPE, MOLECULAR CHARACTERISTICS, AND THERAPY. The second part of plasma cell neoplasms with spreading in the blood and tissues

Giuseppe G.M. Leone, Ugo Testa

Abstract 235 | PDF Downloads 96 Html Downloads 13

Page e2025080

PDF Html

DOI: https://doi.org/10.4084/MJHID.2025.080

LIGHT CHAIN AMYLOIDOSIS

Paolo Milani, Giampaolo Merlini, Giovanni Palladini

Abstract 4941 | PDF Downloads 2112 HTML Downloads 1140

Page e2018022

PDF HTML

DOI: https://doi.org/10.4084/mjhid.2018.022

Effect of Immunoglobulin Therapy on the Rate of Infections in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation and or Treated with Immunomodulatory Agents

Alhossain A. Khalafallah, Matthias Maiwald, Amanda Cox, Burns Denise, Gerald Bates, Terry Hannan, David Seaton, Bernadene Fernandopulle, Terry Brain

Abstract 942 | PDF Downloads 506 HTML Downloads 1075

Page e2010005

PDF HTML

DOI: https://doi.org/10.4084/mjhid.2010.005

The THE PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW: PART 2-FOCUS ON THERAPY

Michele Bibas

Abstract 1240 | PDF Downloads 1386 HTML Downloads 508

Page e2024015

PDF HTML

DOI: https://doi.org/10.4084/MJHID.2024.015

OUTCOME OF PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA RELAPSING AFTER AUTOLOGOUS TRANSPLANT BEFORE AVAILABILITY OF CAR-T CELL TREATMENT

Ulrike Bacher, Stefanie von Matt, Yara Banz, Behrouz Mansouri, Urban Novak, Thomas Pabst

Abstract 986 | HTML Downloads 257 PDF Downloads 817 Suppl. Files Downloads 395

Page e2023025

HTML PDF Suppl. Files

DOI: https://doi.org/10.4084/MJHID.2023.025

POEMS SYNDROME: AN UPDATE

Andrea Nozza

Abstract 2951 | PDF Downloads 1461 HTML Downloads 1342

Page e2017051

PDF HTML

DOI: https://doi.org/10.4084/mjhid.2017.051

EFFECTS OF DARATUMUMAB ON HEMATOPOIETIC STEM CELLS IN PATIENTS WITH MULTIPLE MYELOMA WHO ARE PLANNED TO RECEIVE AUTOLOGOUS TRANSPLANTATION: WHAT’S THE RELEVANCE?

Pellegrino Musto, Dr. Nicola Sgherza

Abstract 1304 | PDF Downloads 698 HTML Downloads 81

Page e2024073

PDF HTML

DOI: https://doi.org/10.4084/MJHID.2024.073

POOR HEMOPOIETIC STEM CELL MOBILIZERS IN MULTIPLE MYELOMA : A SINGLE INSTITUTION EXPERIENCE

Guillermo Jose Ruiz-Delgado, Avril Lopez-Otero, Ana Hernandez-Arizpe, Aura Ramirez-Medina, Guillermo Jose Ruiz-Argüelles

Abstract 1017 | PDF Downloads 651 HTML Downloads 545

Page e2010016

PDF HTML

DOI: https://doi.org/10.4084/mjhid.2010.016

A case of fatal hyperammonaemic encephalopathy in a patient with end-stage Multiple Myeloma treated with daratumumab

Mauro Passucci, Francesca Fazio, Maria Teresa Petrucci

Abstract 670 | PDF Downloads 848 HTML Downloads 361

Page e2023012

PDF HTML

DOI: https://doi.org/10.4084/MJHID.2023.012

The Outcome of Six Patients with COVID-19 Infection and Multiple Myeloma. A Case Series and Literature Review

Hesham Elsabah, Mahmood B. Aldabt, Ruba Taha, Dina Sameh Soliman, Halima Elomri, Feryal Ibrahim

Abstract 744 | PDF Downloads 289 HTML Downloads 126

Page e2020082

PDF HTML

DOI: https://doi.org/10.4084/mjhid.2020.082

Efficacy and safety of teclistamab followed by autologous stem cells transplant in functional high-risk and triple class refractory multiple myeloma

Vincenzo Sammartano, Sara Ciofini, Beatrice Esposito Vangone, Chiara Carrara, Monica Bocchia, Alessandro Gozzetti

Abstract 529 | PDF Downloads 439 HTML Downloads 13

Page e2025051

PDF HTML

DOI: https://doi.org/10.4084/MJHID.2025.051

WALDENSTROM’S MACROGLOBULINEMIA: AN UPDATE

Maddalena Mazzucchelli, Anna Maria Frustaci, Marina Deodato, Roberto Cairoli, Alessandra Tedeschi

Abstract 6896 | PDF Downloads 2255 HTML Downloads 1493 Table 1. Downloads 0 Table 2. Downloads 0 Table 3. Downloads 0 Table 4. Downloads 0

Page e2018004

PDF HTML Table 1. Table 2. Table 3. Table 4.

DOI: https://doi.org/10.4084/mjhid.2018.004

Impact of the Addition of Daratumumab to the Standard Bortezomib-Thalidomide-Dexamethasone Regimen on Hematopoietic Stem Cell Mobilization and Collection, Post-Transplant Engraftment and Infectious Complications: A Case-Control Multicentre Real-Life Analy

Gianluca Cavallaro

Abstract 2027 | HTML Downloads 97 PDF Downloads 1000

Page e2024049

HTML PDF

DOI: https://doi.org/10.4084/MJHID.2024.049

Search

Search Results